Paul Spence Jr. - Dec 15, 2022 Form 4 Insider Report for OptiNose, Inc. (OPTN)

Role
Chief Commercial Officer
Signature
/s/ Anthony Krick, Attorney-in-Fact
Stock symbol
OPTN
Transactions as of
Dec 15, 2022
Transactions value $
$0
Form type
4
Date filed
12/15/2022, 04:16 PM
Next filing
Feb 29, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OPTN Stock Option (Right to Buy) Award $0 +500K $0.00 500K Dec 15, 2022 Common Stock 500K $1.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable over a four-year period commencing on December 15, 2022. Twenty-five percent (25%) of the option vests and becomes exercisable on December 15, 2023, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining three years of the four-year period, subject to continued service with the Issuer.